New incident report
Incident Report Number: 2016-1381
Registrant Reference Number: 1758599
Registrant Name (Full Legal Name no abbreviations): McLaughlin Gormley King Company
Address: 8810 Tenth Ave North
City: Minneapolis
Prov / State: MN
Country: USA
Postal Code: 55427-4319
Human
Country: UNITED STATES
Prov / State: NEVADA
Unknown
PMRA Registration No. PMRA Submission No. EPA Registration No. 1021-1177
Product Name: Pyrocide 300
Yes
Unknown
Site: Res. - In Home / Rés. - à l'int. maison
Other
Sex: Male
Age: <=1 yr / < = 1 an
System
Unknown / Inconnu
Yes
Yes
Unknown
Non-occupational
What was the activity? Please refer to field 13 on Subform II or field 17 of subform III for a detailed description regarding the activity
Other
None
Unknown
Unknown / Inconnu
>3 days <=1 wk / >3 jours <=1 sem
1/21/2016 Caller states that her daughter's apartment was treated with the product sometime in the last two weeks of December 2015. All recommendations were followed to prepare the unit. The family left the unit, and the unit was ventilated and the carpets professionally cleaned prior to their return. On 1/1/2016, caller's (age) month old grandson developed myoclonic movement every 2 hours. The episodes were video taped and shown to his primary doctor, and he was referred for a neurological exam. The doctor admitted the child for an evaluation for neurotoxicity. He was given an electroencephalogram, electromyography, and other tests.
Major
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews. Any relationship between the use of this product and the insidious development of the complications reported in this case is inconceivable and lacks biological plausibility. Secondly, the product use history is extremely vague and lacks any description of a known or defined point of direct exposure to this product. Even had casual or incidental contact with this product occurred, such illness would be unexpected and is not consistent with the toxicological profile of this product..